- Hypertrophic Cardiomyopathy (HCM)
- Eyecare
- Urothelial Carcinoma
- Hemophilia
- Heart Failure
- Vaccines
- Neonatal Care
- NSCLC
- Type II Inflammation
- Substance Use Disorder
- Gene Therapy
- Lung Cancer
- Spinal Muscular Atrophy
- HIV
- Post-Acute Care
- Liver Disease
- Asthma
- Atrial Fibrillation
- COVID-19
- Cardiovascular Diseases
- Prescription Digital Therapeutics
- Reproductive Health
- The Improving Patient Access Podcast
- Blood Cancer
- Ulcerative Colitis
- Respiratory Conditions
- Multiple Sclerosis
- Digital Health
- Population Health
- Sleep Disorders
- Biosimilars
- Plaque Psoriasis
- Leukemia and Lymphoma
- Oncology
- Pediatrics
- Urology
- Obstetrics-Gynecology & Women's Health
- Opioids
- Solid Tumors
- Autoimmune Diseases
- Dermatology
- Diabetes
- Mental Health
Chronicles of Bad Times at the CDC: Mistakes, White House Meddling
Reporters at ProPublica, The Wall Street Journal and Science have written in-depth accounts of CDC's faded role, damaged reputation and White House interference.
The CDC is the subject of three in-depth news reports that paint a portrait of the agency’s mistakes, diminished role in the federal government's response to the COVID-19 pandemic and interference by the White House.
ProPublica’s story, titled “Inside the Fall of the CDC,” is a closely reported, chronological account that starts on December 31st when Anne Schuchat, a CDC career scientists who was played by Kate Winslet in the movie “Contagion,” emails colleagues about an “unknown pneumonia” in Wuhan. The four-reporter team takes the reader through the bad and lack of information the CDC got from their Chinese health counterparts, the agency’s initial bungling of COVID-19 testing, and many episodes of White House interference.
“Senior CDC staff describe waging battles that are as much about protecting science from the White House as protecting the public from COVID-19. It is a war that they, more often than not, lost,” says the ProPublica piece.
The Wall Street Journal’s story is shorter but covers some of the same ground (both stories begin with accounts of the White House meddling with CDC guidelines for houses of worship). The headline on the Journal’s story is “A Demoralized CDC Grapples With White House Meddling and Its Own Mistake."
The third story, published in Science, the prestigious science journal, zeroes in on the relationship between Deborah Birx, M.D., the coordinator of White House coronavirus task force, and the CDC. The story, headlined “The Inside Story of How Trump’s COVID-19 Coordinator Undermined the World’s Top Health Agency,” describes Birx as sidelining the agency and goes into detail about her decision to depend on a private company, TeleTracking Technologies, to collect COVID-19 hospital data instead of the CDC’s system.
The ProPublica and Wall Street Journal stories were published within hours of each other earlier today. The Science article was published yesterday.
35th World AIDS Day Marks 20 Years of PEPFAR: Challenges and Strategies to Combat HIV/AIDS
November 29th 2023PEPFAR, having invested $100 billion and saved 25 million lives in the global fight against HIV/AIDS, faces Congressional hurdles in its reauthorization due to abortion debates. Despite widespread support and no evidence of abortion-related activities, the legislative process is at a standstill. Members of PEPFAR and authors of a recent editorial stress the significance of PEPFAR and advocate for integrating behavioral and social science into healthcare programs to achieve UNAIDS targets and address barriers in HIV/AIDS testing and treatment.
Read More
Bridging the Diversity Gap in Rare Disease Clinical Trials with Harsha Rajasimha of IndoUSrare
November 8th 2023Briana Contreras, an editor with Managed Healthcare Executive, spoke with Harsha Rajasimha, MD, founder and executive chairman of IndoUSrare, in this month's episode of Tuning in to the C-Suite podcast. The conversation was about how the disparity in diversity and ethnicity in rare disease clinical trials in the U.S. has led to gaps in understanding diseases and conditions, jeopardizing universal health, and increasing the economic burden of healthcare.
Listen
Managing Editor of Managed Healthcare Executive, Peter Wehrwein, had a discussion with William Shrank, M.D., a venture partner with Andreessen Horowitz, a venture capital firm in Menlo Park, California, about how artificial intelligence's role is improving healthcare, where we are today with value-based care and the ongoing efforts of reducing waste in the healthcare space for this episode of the "What's on Your Mind" podcast series.
Listen
